Lithium Ion

Lithium Ion

SCHEMBL7234683

CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(C(=O)[O-])c2)CC1.[Li+]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ HTT P42858 2/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ PDK2 Q15119 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.48
▸ GPR119 Q8TDV5 5/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NAMPT P43490 1/20 0.46
▸ ALK Q9UM73 2/20 0.46
▸ SUV39H2 Q9H5I1 1/20 0.46
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232828 0.88 MAPT (0.55) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL7234678 0.87 MAPT (0.54) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL1786153 0.87 MAPT (0.54) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL15797078 0.85 MAPT (0.72) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL30208188 0.85 MAPT (0.72) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL7235368 0.83 MAPT (0.63) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL10063610 0.83 MAPT (0.59) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL24511558 0.81 MAPT (0.56) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL7242118 0.81 MAPT (0.56) MAPTALDH1A1LMNASMN1; SMN2HTT
SCHEMBL21533625 0.81 MAPT (0.63) MAPTALDH1A1LMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555541-B1 P2X7 receptor antagonists for treatment of inflammatory respiratory system disorders such as asthma; for example, 2-(3,4-Difluorophenylamino)-N-(2-methyl-5-piperazin-1-yl-methyl-phenyl) -acetamide, trihydrochloride ASTRAZENECA UK LIMITED (GB) 2003-04-29 — — US disclosed
Send feedback